SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-005325
Filing Date
2017-01-24
Accepted
2017-01-24 17:36:39
Documents
1
Period of Report
2017-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4084
  Complete submission text file 0001209191-17-005325.txt   5481
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Renz Justin A (Reporting) CIK: 0001466562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 17544606

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences